检索结果 - Xing-Mei Cao

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis

    Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis 由 Cong Dai, Tiansong Zhang, Shuai Lin, Wanggang Zhang, Jie Liu, Xing-Mei Cao, Hong‐Bao Li, Meng Wang, Xinghan Liu, Kang Liu, Shanli Li, Zhijun Dai

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    A novel multi‐epitope vaccine from <scp>MMSA</scp>‐1 and <scp>DKK</scp>1 for multiple myeloma immunotherapy

    A novel multi‐epitope vaccine from <scp>MMSA</scp>‐1 and <scp>DKK</scp>1 for multiple myeloma immunotherapy 由 Chenyang Lu, Shan Meng, Yanxia Jin, Wanggang Zhang, Zongfang Li, Fang Wang, Feng Wang‐Johanning, Yongchang Wei, Hailing Liu, Honglei Tu, Dan Su, Aili He, Xing-Mei Cao, Fuling Zhou

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

    A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple my... 由 Wanhong Zhao, Jie Liu, Baiyan Wang, Yinxia Chen, Xing-Mei Cao, Yun Yang, Yilin Zhang, Fangxia Wang, Pengyu Zhang, Bo Lei, Liufang Gu, Jianli Wang, Nan Yang, Ru Zhang, Hui Zhang, Ying Shen, Ju Bai, Yan Xu, Xugeng Wang, Ruili Zhang, Lili Wei, Zongfang Li, Zhenzhen Li, Yan Geng, Qian He, Qiu-Chuan Zhuang, Xiao-Hu Fan, Aili He, Wanggang Zhang

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

    Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Matu... 由 Baiyan Wang, Wanhong Zhao, Jie Liu, Yinxia Chen, Xing-Mei Cao, Yun Yang, Yilin Zhang, Fangxia Wang, Pengyu Zhang, Bo Lei, Liufang Gu, Jianli Wang, Jiajia Zhang, Ru Zhang, Hui Zhang, Ying Shen, Ju Bai, Yan Xu, Xugeng Wang, Ruili Zhang, Lili Wei, Zongfang Li, Gaixia He, Yan Geng, Qian He, Qiu-Chuan Zhuang, Frank Fan, Wanggang Zhang, Aili He

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2) 由 Wanhong Zhao, Baiyan Wang, Lijuan Chen, Weijun Fu, Jie Xu, Jie Liu, S Jin, Yinxia Chen, Xing-Mei Cao, Yun Yang, Yilin Zhang, Fangxia Wang, Pengyu Zhang, Bo Lei, Liufang Gu, Jianli Wang, Hui Zhang, Ju Bai, Yan Xu, Han Zhu, Juan Du, Hua Jiang, Xiao-Hu Fan, Jianyong Li, Jian Hou, Chen Zhu, Wanggang Zhang, Jian‐Qing Mi, Sai‐Juan Chen, Aili He

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: